JDRF, the UK Type 1 diabetes charity and INPUT Patient Advocacy, the UK diabetes technology advocacy charity, have announced plans to combine their organisations in order to work together to improve the lives of people with Type 1 diabetes. This merger will unite two strong voices for people with Type 1 diabetes in the UK in a shared mission to accelerate the progress of research to cure, treat and prevent Type 1 diabetes, and improve access to new treatments and technologies.
Karen Addington, UK Chief Executive of JDRF says, “JDRF and INPUT have worked together closely for over a decade, sharing expertise and insights to improve the lives of people with Type 1 diabetes. JDRF’s global research programme has been driving the development of new treatments for Type 1 diabetes including the artificial pancreas, encapsulated islets and glucose-responsive insulin. As many of these treatments move closer to reality, it is essential that we support and facilitate their swift adoption by the NHS.”
Lesley Jordan, INPUT Chief Executive, adds, “Linking JDRF’s world-class research with INPUT’s expertise in diabetes technology access will increase INPUT’s capacity to tackle individual, local and national access issues. Together, we will help more people gain access to diabetes technology, now and in the future. Input will continue to exist but within JDRF and will be still available to give advice to people with Type 2 diabetes regarding access to technology, should they need it. This merger will take away some of the back-office admin, leaving us freer to focus our energy on doing more advocacy, which is where we feel we most need to get our messages across.”
JDRF in the UK is part of a global network of charities, which together make the world’s leading charitable funder of Type 1 diabetes research. For 20 years, INPUT has supported people living with diabetes, advocating for easier access to diabetes technology across the UK, such as insulin pump therapy, flash and continuous glucose monitoring and structured education.
INPUT and JDRF will start to work together from the JDRF London offices from July, with the formal merger planned for October 2018.
News items and features like this appear in the Desang Diabetes Magazine, our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it’s free, and you can easily unsubscribe should you wish to).